Sumatriptan in Acute Migraine
The efficacy of oral sumatriptan 100 mg in 61 patients with acute migraine was assessed in a double blind, randomized, placebo-controlled, crossover study at the Department of Neurology, The Prince Henry and Prince of Wales Hospitals, Sydney, and Austin Hospital and Repatriation General Hospital, Me...
Main Author: | J Gordon Millichap |
---|---|
Format: | Article |
Language: | English |
Published: |
Pediatric Neurology Briefs Publishers
1991-10-01
|
Series: | Pediatric Neurology Briefs |
Subjects: | |
Online Access: | https://www.pediatricneurologybriefs.com/articles/3138 |
Similar Items
-
Sumatriptan Nasal Spray for Acute Migraine
by: J Gordon Millichap
Published: (1997-12-01) -
Intravenous Valproate versus Subcutaneous Sumatriptan in Acute Migraine Attack
by: Fahmida Ghaderibarmi, et al.
Published: (2015-10-01) -
Efficacy and safety of DFN-11 (sumatriptan injection, 3 mg) in adults with episodic migraine: a multicenter, randomized, double-blind, placebo-controlled study
by: Stephen Landy, et al.
Published: (2018-08-01) -
Comparison between Intravenous Sodium Valproate and Subcutaneous Sumatriptan for Treatment of Acute Migraine Attacks; Double-Blind Randomized Clinical Trial
by: Abolghasem Rahimdel, et al.
Published: (2014-03-01) -
From investigational product to active reference: evolution of oral sumatriptan efficacy versus placebo for the treatment of acute migraine episodes and potential impact in comparative analyses
by: Katia Thokagevistk, et al.
Published: (2019-01-01)